Type of MS: RRMS|SPMS
Treatment mode of action: To affect immune function
Number of Subjects: 3
Medication: ocrelizumab
Location: Colorado
Institutions: Advanced Neurosciences Research of Colorado
Contact Information
Paul Miller,Sylvia Akmakjian,Lillie Denny
(970) 226-6111
pmmiller1@aol.com